Managerial accounting An independent evaluator from the Enhanced High Growth Initiative was appointed to monitor the HEIF 3 funded SPEED programme, specifically to evaluate the academic benefits and dissemination of academic knowledge resulting from the SPEED programme.

31 1. Why is weight monitored in infants on methylphenidate for the treatment of attention deficit hyperactivity disorder (ADHD)? Is this to prevent them losing weight, or is losing a certain amount of weight acceptable? 2. Should the electroencephalogram (EEG) be monitored in patients on methylphenidate for ADHD treatment? Should this be stopped if there is some epileptic discharge?

32 What is the safest typical and atypical antipsychotic, antidepressant and serotonin re-uptake inhibitor (SSRI) used to treat obsessive-compulsive disorder (OCD) that can be used during pregnancy?

33 What is the rationale for combining serotonin re-uptake inhibitor (SSRIs) and clomipramine in patients with obsessive-compulsive disorder (OCD)? Is this combination more effective than any agent when given alone?

34 Is sertraline superior to fluoxetine in the treatment of obsessivecompulsive disorder and, if so, why?

35 I want to find out if there is really a correlation between all cases of delirium tremens (DT) and thiamine deficiency. DT is meant to be a withdrawal state and I assume it can happen in well-nourished alcoholics, as not all alcoholics are malnourished. My friends and I have seen the question that DT is associated with thiamine deficiency in question papers and it has really proved a thorny issue.

36 1. How long should a doctor treat a patient with the first episode of schizophrenia with regard to the active phase and maintenance therapy? 2. In a patient presenting with the third psychotic episode fulfilling the criteria of schizophrenia, for how long should antipsychotic treatment be continued?

37 Is there a rationale for treating a patient presenting with his first psychotic episode fulfilling the criteria for schizophrenia, with atypical antipsychotics?

38 What is the rationale for giving a patient with resistant schizophrenia a combination of typical and atypical antipsychotics?

39 Do selective serotonin re-uptake inhibitors (SSRIs) have an antiaggression effect and what is the best anti-aggression drug to be given to schizophrenics and to those suffering from other mental illnesses?

40 Is depot fluphenazine alone sufficient to treat the active phase of schizophrenia and, if so, what dose is recommended?